[1] WONG L S， OESEBURG H， DE BOER R A， et al. Telomere biology in cardiovascular disease： the TERC-/- mouse as a model for heart failure and ageing[J]. Cardiovasc Res，2009，81(2：244-252.
[2] SATO R，MAESAWA C，FUJISAWA K， et al. Prevention of critical telomere shortening by oestradiol in human normal hepatic cultured cells and carbon tetrachloride induced rat liver fibrosiis[J]. Gut，2004，53(7：1001-1009.
[3] COHEN S B， GRAHAM M E， LOVRECZ G O， et al. Protein composition of catalytically active huamn telomerase from immortal cells[J]. Science，2007，315(5820：1850-1853.
[4] CAO Y， BRYAN T M， REDDEL R R. Increased copy number of the TERT and TERC telomerase subunit genes in cancer cells[J]. Cancer Sci，2008，99(6：1092-1099.
[5] HARLEY C B，FUTCHER A B，GREIDER C W. Telomeres shorten during ageing of human fibroblasts[J]. Nature，1990，345(6274：458-460.
[6] MAIDA Y， YASUKAWA M， FURUUCHI M， et al. An RNA-dependent RNA polymerase formed by TERT and the RMRP RNA[J]. Nature， 2009，461(7261：230-235.
[7] CONG Y， SHAY J W. Actions of human telomerase beyond telomeres[J]. Cell Res，2008，18(7：725-732.
[8] PARKINSON E K， FITCHETT C， CERESER B. Dissecting the non-canonical functions of telomerase[J]. Cytogenet Genome Res， 2008，122(3-4：273-280.
[9] BOLLMANN F M. The many faces of telomerase： emerging extratelomeric effects[J]. Bioessays，2008，30(8：728-732.
[10] COUNTER C M， HAHN W C， WEI W， et al. Dissociation among in vitro telomerase activity， telomere maintenance， and cellular immortalization[J]. Proc Natl Acad Sci USA， 1998，95(25：14723-14728.
[11] MASUTOMI K， POSSEMATO R， WONG J M， et al. The telomerase reverse transcriptase regulates chromatin state and DNA damage responses[J]. Proc Natl Acad Sci USA， 2005，102(23：8222-8227.
[12] GONZ LEZ-SU REZ E， SAMPER E， RAM REZ A， et al. Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase， mTERT， in basal keratinocytes[J]. EMBO J，2001，20(11：2619-2630.
[13] CAYUELA M L， FLORES J M，BLASCO M A. The telomerase RNA component Terc is required for the tumour-promoting effects of Tert overexpression[J]. EMBO Rep， 2005，6(3：268-274.
[14] FLORES I， CAYUELA M L, BLASCO M A. Effects of telomerase and telomere length on epidermal stem cell behavior[J]. Science, 2005，309(5738：1253-1256.
[15] SARIN K Y, CHEUNG P, GILISON D， et al. Conditional telomerase induction causes proliferation of hair follicle stem cells[J]. Nature, 2005，436(7053：1048-1052.
[16] CHOI J, SOUTHWORTH L K, SARIN K Y， et al. TERT promotes epithelial proliferation through transcriptional control of a Myc- and Wnt-related developmental program[J]. PLoS Genet， 2008，4(1：10.
[17] SIEGL-CACHEDENIER I, FLORES I, KLATT P， et al. Telomerase reverses epidermal hair follicle stem cell defects and loss of long-term survival associated with critically short telomeres[J]. J Cell Biol， 2007， 179(2：277-290.
[18] KONDO Y，KONDO S，TANAKA Y， et al. Inhibition of telomerase increases the susceptibility of human malignant glioblastoma cells to cisplatin-induceda poptosis[J]. Oncogene，1998， 16(17：2243-2248.
[19] GORBUNOVA V，SELUANOV A，PEREIRA-SMITH O M. Expression of human telomerase (hTERT does not prevent stress-induced senescence in normal human fibroblasts but protects the cells from stress-induced apoptosis and necrosis[J]. J Biol Chem，2002，277(41：38540-38549.
[20] ZHU H，FU W，MATTSON M P. The catalytic subunit of telomerase protects neurons against amyloid b-peptide-induced apoptosis[J]. J Neurochem，2000，75(1：117-124.
[21] OH H，TAFFET G E，YOUKER K A， et al. Telomerase reverse transcriptase promotes cardiac muscle cell proliferation， hypertrophy， and survival[J]. Proc Natl Acad Sci USA，2001，98(18：10308-10313.
[22] KANG H J，CHOI Y S，HONG S B， et al. Ectopic expression of the catalytic subunit of telomerase protects against brain injury resulting from ischemia and NMDA-induced neurotoxicity[J]. J Neurosci， 2004，24(6：1280-1287.
[23] CAO Y，LI H，DEB S， et al. TERT regulates cell survival independent of telomerase enzymatic activity[J]. Oncogene，2002， 21(20：3130-3138.
[24] RAHMAN R，LATONEN L，WIMAN K G. hTERT Antagonizes p53-induced apoptosis independently of telomerase activity[J]. Oncogene，2005，24(8： 1320-1327.
[25] LEE J，SUNG Y H，CHEONG C， et al. TERT Promotes cellular and organismal survival independently of telomerase activity[J]. Oncogene，2008，27(26： 3754-3760.
[26] AHMED S，PASSOS J F，BIRKET M J， et al. Telomerase does not counteract telomere shortening but protects mitochondrial function under oxidative stress[J]. J Cell Sci，2008，121(Pt 7：1046-1053.
[27] HAENDELER J， DRSE S， BCHNER N， et al. Mitochondrial telomerase reverse transcriptase binds to and protects mitochondrial DNA and function from damage[J]. Arterioscler Thromb Vasc Biol，2009，29(6：929-935.
[28] SANTOS J H， MEYER J N，VAN HOUTEN B. Mitochondrial localization of telomerase as a determinant for hydrogen peroxide-induced mitochondrial DNA damage and apoptosis[J]. Hum Mol Genet，2006，15(11：1757-1768.
[29] BELIVEAU A， YASWEN P. Soothing the watchman： telomerase reduces the p53-dependent cellular stress response[J]. Cell Cycle，2007，6(11：1284-1287.
[30] DAIRKEE S H， NICOLAU M， SAYEED A，et al. Oxidative stress pathways highlighted in tumor cell immortalization： association with breast cancer outcome[J]. Oncogene，2007，26(43：6269-6279.
[31] MASSARD C， ZERMATI Y， PAULEAU A L， et al. hTERT： a novel endogenous inhibitor of the mitochondrial cell death pathway[J]. Oncogene，2006，25(33：4505-4514.
[32] PASSOS J F， SARETZKI G， VON ZGLINICKI T. DNA damage in telomeres and mitochondria during cellular senescence： is there a connection[J]. Nucleic Acids Res， 2007，35(22：7505-7513.
[33] SEIMIYA H， SAWADA H， MURAMATSU Y， et al. Involvement of 14-3-3 proteins in nuclear localization of telomerase[J]. Embo J，2000，19(11：2652-2661.
[34] JAKOB S， ALTSCHMIED J， HAENDELER J. "Shping 2" different cellular localizations - a potential new player in aging processes[J]. Aging (Albany NY， 2009，1(7：664-668.
[35] LEE J， JO Y S， SUNG Y H， et al. Telomerase deficiency affects normal brain functions in mice[J]. Neurochem Res，2010，35(2：211-218.
[36] SASAKI M， IKEDA H， YAMAGUCHI J， et al. Telomere shortening in the damaged small bile ducts in primary biliary cirrhosis reflects ongoing cellular senescence[J]. Hepatology，2008，48(1：186-195.
[37] NAKAJIMA T， MORIGUCHI M， KATAGISHI T， et al. Premature telomere shortening and impaired regenerative response in hepatocytes of individuals with NAFLD[J]. Liver Int，2006， 26(1：23-31.
[38] PARADIS V， YOUSSEF N， DARGERE D，et al. Replicative senescence in normal liver，chronic hepatitis C， and hepatocellular carcinomas[J]. Hum Pathol，2001，32(3：327-332.
[39] KITADA T，SEKI S，KAWAKITA N， et al. Telomere shortening in chronic liver diseases[J]. Biochem Biophys Res Commun，1995，211(1：33-39.
[40] WIEMANN S U，SATYANARAYANA A，TSAHURIDU M， et al. Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis[J]. Faseb J，2002，16(9：935-942.
[41] TAHARA H， NAKANISHI T， KITAMOTO M， et al. Telomerase activity in human liver tissues： comparison between chronic liver disease and hepatocellular carcinomas[J]. Cancer Res，1995，55(13：2734-2736.
[42] KAWAKAMI Y， KITAMOTO M， NAKANISHI T， et al. Immuno-histochemical detection of human telomerase reverse transcriptase in human liver tissues[J]. Oncogene，2000，19(34：3888-3893.
[43] PARK Y M， CHOI J Y， BYUN B H， et al. Telomerase is strongly activated in hepatocellular carcinoma but not in chronic hepatitis and cirrhosis[J]. Exp Mol Med，1998，30(1：35-40.
[44] TAHARA H，NAKANISHI T，KITAMOTO M， et al. Telomerase activity in human liver tissues： comparison between chronic liver disease and hepatocellular carcinomas[J]. Cancer Res，1995，55(13：2734-2736.
[45] HARADA K， YASOSHIMA M， OZAKI S， et al. PCR and in situ hybridization studies of telomerase subunits in human non-neoplastic livers[J]. J Pathol， 2001， 193(2： 210-217.
[46] SCHNABL B， CHOI Y H， OLSEN J C， et al. Immortal activated human hepatic stellate cells generated by ectopic telomerase expression[J]. Lab Invest，2002， 82(3：323-333.
[47] RUDOLPH K L， CHANG S， MILLARD M， et al. Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery[J]. Science，2000，287(5456：1253-1258.
[48] CAI W M. New progress in anti-hepatic fibrosis drug [J]. Chin Pharm J(中国药学杂志，2008， 43(3： 161-164.